After big jumps, digoxin rollercoaster falls 82% in Q3 ASP drug pricing

Why This Topic Matters

ASP pricing updates affect Medicare Part B reimbursement and can change how injectable and other covered drug claims are priced. Tracking unusual price movements helps organizations stay current with payment changes and understand broader market trends affecting drug costs.

Article Sections

1. ASP pricing update overview

   A general summary of the latest CMS quarterly ASP drug pricing file and the timing of the update for Medicare payment purposes.

2. Notable price changes in the Q3 list

   Discussion of selected drugs with especially large quarter-to-quarter price movements, including both decreases and increases.

3. Context for broader pricing trends

   Background on market and regulatory factors that may relate to recent drug pricing movement and overall average changes across the list.